[1]
S. Amir, F. Laique, and M. M. Azam, “Unlocking hope: talquetamab in multiple myeloma treatment: a bispecific breakthrough targeting CD3 and GPRC5D”, Int J Sci Rep, vol. 10, no. 6, pp. 221–224, May 2024.